Cargando…
TCR hypervariable regions expressed by T cells that respond to effective tumor vaccines
A major goal of immunotherapy for cancer is the activation of T cell responses against tumor-associated antigens (TAAs). One important strategy for improving antitumor immunity is vaccination with peptide variants of TAAs. Understanding the mechanisms underlying the expansion of T cells that respond...
Autores principales: | Jordan, Kimberly R., Buhrman, Jonathan D., Sprague, Jonathan, Moore, Brandon L., Gao, Dexiang, Kappler, John W., Slansky, Jill E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3410973/ https://www.ncbi.nlm.nih.gov/pubmed/22350070 http://dx.doi.org/10.1007/s00262-012-1217-5 |
Ejemplares similares
-
Improving Antigenic Peptide Vaccines for Cancer Immunotherapy Using a Dominant Tumor-specific T Cell Receptor
por: Buhrman, Jonathan D., et al.
Publicado: (2013) -
Mimotope vaccine efficacy gets a "boost" from native tumor antigens
por: Buhrman, Jonathan D., et al.
Publicado: (2013) -
The Goldilocks Model for TCR—Too Much Attraction Might Not Be Best for Vaccine Design
por: Slansky, Jill E., et al.
Publicado: (2010) -
Structures suggest an approach for converting weak self-peptide tumor antigens into superagonists for CD8 T cells in cancer
por: Wei, Pengcheng, et al.
Publicado: (2021) -
Tracking TCRβ Sequence Clonotype Expansions during Antiviral Therapy Using High-Throughput Sequencing of the Hypervariable Region
por: Robinson, Mark W., et al.
Publicado: (2016)